Detheux Michel (CIK 1816196) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-08-29). Recent activity: Sell ITOS (153,903 shares), Sell ITOS (94,027 shares), Buy ITOS (8,400 shares), Sell ITOS (8,400 shares), Buy ITOS (43,882 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-29 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 153,903 | $0 |
| 2025-08-29 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 94,027 | $0 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 8,400 | $36,120 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 8,400 | $84,252 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 43,882 | $188,693 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 43,882 | $440,136 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 8,400 | $36,120 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 8,400 | $84,168 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 43,883 | $188,697 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 43,883 | $439,708 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 18,000 | $77,400 |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 94,027 | $404,316 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 8,400 | $36,120 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 8,400 | $84,840 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 43,883 | $188,697 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 43,883 | $443,218 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 8,400 | $36,120 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 8,400 | $85,260 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 43,882 | $188,693 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 43,882 | $445,402 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 8,400 | $36,120 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 8,400 | $85,764 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 43,882 | $188,693 |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Sell | 43,882 | $448,035 |
| 2025-03-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Executive Officer | Buy | 77,000 | $0 |
Source: SEC Form 4 filings · as of 2025-08-29